引用本文:王晓刚(综述),韦智晓(审校).核素显像在分化型甲状腺癌术后随访中的应用[J].中国临床新医学,2010,3(2):197-200.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1191次   下载 1193 本文二维码信息
码上扫一扫!
分享到: 微信 更多
核素显像在分化型甲状腺癌术后随访中的应用
王晓刚(综述),韦智晓(审校)
530021 南宁,广西医科大学第一附属医院核医学科
摘要:
[摘要] 分化型甲状腺癌术后往往需要用131I进一步清除术后残留的甲状腺功能组织并治疗可能存在的转移灶,以减少术后的复发率和转移率,核素显像在该病术后制定下一步诊疗方案、判断预后以及评价疗效等方面均有较大的应用价值。本文就核素显像在分化型甲状腺癌术后的应用进行综述。
关键词:  核素显像  分化型甲状腺癌
DOI:10.3969/j.issn.1674-3806.2010.02.43
分类号:R 736.1
基金项目:
Clinical application of radionuclide imaging in postoperative follow-up of the patients with differentiated thyroid carcinoma
WANG Xiao-gang,WEI Zhi-xiao
The First Affiliated Hospital of Gunagxi Medical University,Nanning 530021,China
Abstract:
[Abstract] Postoperative patients with differentiated thyroid carcinoma often need undergoing iodine-131 to further eliminate residual thyroid tissue and treat metastatic lesions that may exist to reduce the rate of recurrence and matastasis. Scintigraphy has a big appliation value in formulation of the next diagnosing and treating plan,judgment of prognosis and appraisal of curative effect and so on. This article carries on the summary on the application of radionuclide imaging after the operation of differentiated thyroid carcinoma.
Key words:  Radionuclide imaging  Differentiated thyroid carcinoma